Advertisement
Person › Details
David Meek (FerGene (Ferring / Blackstone Life Sciences))
Meek, David (Ferring 202001– CEO of FerGene before Ipsen + Baxalta + Endocyte + Novartis + JnJ)
Organisation | Ipsen S.A. (Euronext: IPN; ADR: IPSEY) | |
Group | Ipsen (Group) | |
Product | pharmaceutical | |
Record changed: 2020-04-05 |
Advertisement
More documents for David Meek
- [1] Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris....
- [2] Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA....
- [3] Uniqure N.V.. (6/13/18). "Press Release: Uniqure Announces New Appointments to its Board of Directors". Lexington, MA & Amsterdam....
- [4] Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris....
- [5] Ipsen S.A.. (2/13/17). "Press Release: Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi". Paris....
- [6] Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top